Smallpox Discovery Prompts FDA Action Plan; Move To White Oak Unchanged
Executive Summary
FDA scientist’s discovery of decades-old vials of smallpox at lab on NIH campus are a reminder of the unsettled debate on whether governments should keep smallpox stock to aid development of antivirals.
You may also be interested in...
Keeping Track: DMD, RMAT, HIV, BTDs, Tc-99m – FTW
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: Approvals, A Burst Of Submissions, And Some Priority Reviews
The latest drug development news and highlights from our US FDA Performance Tracker.
FDA Winding Down White Oak Construction; Outside Rents Going Up
President Obama’s budget requests less headquarters consolidation funding in FY 2015 as CBER announces it will move staff to the campus between May and July.